Cold Atmospheric Plasma Device Extension Study
NCT: NCT05937672 · TERMINATED
Brief Summary
Patients between 4-21 years of age with at least one wart or molluscum lesion are eligible to participate in this study. The duration of the study is a minimum of 4 weeks with the maximum duration of monthly treatments for one year, depending on lesion clearance. The number of lesions will be chosen by the dermatologist. Patients who opt to participate will receive non-thermal, or cold, atmospheric plasma to treat all lesions selected. Safety profile as well as changes in size, pain and appearance will be measured. Photographs and dermatologist impressions will be used to measure treatment response.
Frequently Asked Questions
What is Cold Atmospheric Plasma Device Extension Study?
Cold Atmospheric Plasma Device Extension Study is a clinical trial registered under NCT05937672. Current status: TERMINATED.
What is the status of NCT05937672?
The current status of NCT05937672 (Cold Atmospheric Plasma Device Extension Study) is: TERMINATED.
When did Cold Atmospheric Plasma Device Extension Study start?
Cold Atmospheric Plasma Device Extension Study started on 2023-09-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.